You are here

News

Press Releases

Press Release | September 17, 2020

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests have reached more than 150 million, based on the latest data from the association’s COVID-19 testing supply registry.

Press Release | August 20, 2020

WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement:

Press Release | August 4, 2020

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest data from the association’s national testing registry.